157 related articles for article (PubMed ID: 36235613)
1. Application of the Clustering Technique to Multiple Nutritional Factors Related to Inflammation and Disease Progression in Patients with Inflammatory Bowel Disease.
Dąbek-Drobny A; Kaczmarczyk O; Piątek-Guziewicz A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Zagrodzki P; Zwolińska-Wcisło M
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235613
[TBL] [Abstract][Full Text] [Related]
2. Association between fecal levels of Short-Chain Fatty Acids and serum Pro- and Anti-Inflammatory Cytokines in patients with Inflammatory Bowel Disease.
Kaczmarczyk O; Dąbek-Drobny A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Piątek-Guziewicz A; Wcisło K; Zagrodzki P; Zwolińska-Wcisło M
Folia Med Cracov; 2022 Jun; 62(1):43-55. PubMed ID: 36088592
[TBL] [Abstract][Full Text] [Related]
3. The Importance of Nutritional Aspects in the Assessment of Inflammation and Intestinal Barrier in Patients with Inflammatory Bowel Disease.
Kaczmarczyk O; Dąbek-Drobny A; Piątek-Guziewicz A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Szczyrk U; Strzałka M; Zagrodzki P; Zwolińska-Wcisło M
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364889
[TBL] [Abstract][Full Text] [Related]
4. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment.
Wen N; Zhao N; Xu H; Zhao Y; Ma J
Ir J Med Sci; 2022 Oct; 191(5):2105-2111. PubMed ID: 34843071
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.
Tedelind S; Westberg F; Kjerrulf M; Vidal A
World J Gastroenterol; 2007 May; 13(20):2826-32. PubMed ID: 17569118
[TBL] [Abstract][Full Text] [Related]
7. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF-
Shu W; Pang Z; Xu C; Lin J; Li G; Wu W; Sun S; Li J; Li X; Liu Z
Mediators Inflamm; 2019; 2019():4038619. PubMed ID: 31814801
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation.
Xie C; Yan W; Quan R; Chen C; Tu L; Hou X; Fu Y
Cytokine; 2020 Mar; 127():154963. PubMed ID: 31927461
[TBL] [Abstract][Full Text] [Related]
11. Soluble Protein Hydrolysate Ameliorates Gastrointestinal Inflammation and Injury in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice.
Wei J; Tao G; Xu B; Wang K; Liu J; Chen CH; Dunn JCY; Currie C; Framroze B; Sylvester KG
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139127
[TBL] [Abstract][Full Text] [Related]
12. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
[TBL] [Abstract][Full Text] [Related]
13. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
14. JNK pathway-associated phosphatase illustrates low expression and negative correlations with inflammation, disease activity, and T-helper 17 cells in inflammatory bowel disease children.
Wang C; Bai C; Mao C; Leng X; Wang F; Guo X
J Clin Lab Anal; 2022 Sep; 36(9):e24488. PubMed ID: 35908771
[TBL] [Abstract][Full Text] [Related]
15. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
[TBL] [Abstract][Full Text] [Related]
16. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.
Saiz-Gonzalo G; Hanrahan N; Rossini V; Singh R; Ahern M; Kelleher M; Hill S; O'Sullivan R; Fanning A; Walsh PT; Hussey S; Shanahan F; Nally K; O'Driscoll CM; Melgar S
Front Immunol; 2021; 12():655960. PubMed ID: 34394073
[TBL] [Abstract][Full Text] [Related]
18. Role of cytokines in inflammatory bowel disease.
Sanchez-Munoz F; Dominguez-Lopez A; Yamamoto-Furusho JK
World J Gastroenterol; 2008 Jul; 14(27):4280-8. PubMed ID: 18666314
[TBL] [Abstract][Full Text] [Related]
19. Assessment of anti-inflammatory efficacy of acupuncture in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Yang X; He M; Tang Q; Wang Z; Jin D; Wu X; Yang Y; Ma D; Sun M; Li T
Complement Ther Med; 2023 Jun; 74():102946. PubMed ID: 36997007
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
Fonseca-Camarillo G; Yamamoto-Furusho JK
Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
